Cupid Q2 FY27 Share Price & Earnings Call Analysis
Part of: Nifty Smallcap 250 · NIFTY Smallcap 100 · Nifty MidSmallcap 400 · Nifty 500 · Nifty Total Market
- Market cap
- ₹49,194 Cr
- P/E
- 290.22
- ROE
- 27.64%
- PEG
- 5.61
- Price to sales
- 81.66
- Debt to equity
- 0.20
- 52W high / low
- ₹525 / ₹76.2
- Sales growth (5Y)
- 20.09%
- EBITDA margin
- 38.69%
- Net profit margin
- 30.64%
- Promoter holding
- 47.69%
- Sales (last year)
- ₹602 Cr
Established in 1993, CUPID Limited is India's premier manufacturer of male and female condoms, personal lubricant, and IVD kits.[1]
Guidance scorecard · Q2 FY27 call
What Cupid's management guided
and where it ranks in Personal Products
RevenueQ3 FY24 call
40%+- Post expansion, expected revenue to rise close to Rs. 400 crores (vs. earlier Rs. 320 crores).
- EBITDA anticipated to exceed Rs. 100 crores after expansion completion.
- Capacity to increase by 300 million male condoms by end of 2024, adding to existing 480 million capacity.
- Female condom sales expected to significantly rise in Q4 FY24, contributing Rs. 21 crores.
- Target to double sales from Rs. 160 crores in FY23 over next 3-4 years, factoring in acquisition and expansion.
- Expansion supported by acquisition plans both in India and internationally to broaden product portfolio (condoms and IVD kits).
2 more points from Cupid's call on revenue
Create a free account to keep reading this call
MarginsQ3 FY24 call
Up 2%+See what Cupid said on margins — free account, 30 seconds.
CapexQ3 FY24 call
Planned- Cupid Limited has acquired a land parcel and plans to commence new production lines within approximately two years as part of their expansion.
- They are increasing male condom manufacturing capacity, aiming to add about 300 million units by the end of 2024, raising total capacity from 480 million units.
- A significant portion of the recently raised Rs. 385-400 crore through share issuance is earmarked for strategic acquisitions, particularly outside India, targeting condom and IVD (In Vitro Diagnostics) businesses.
- The company is focused on acquisitions that will expand product lines within the condom segment and potentially accelerate approvals for IVD products.
- Apart from acquisitions, a small portion of funds will be used for working capital needs.
2 more points from Cupid's call on capex
Create a free account to keep reading this call
FundraisingQ3 FY24 call
PlannedSee what Cupid said on fundraising — free account, 30 seconds.
Order bookQ3 FY24 call
- Current order book: Rs. 80 crores
- Backlog related to female condoms in Q4 to be cleared: Rs. 21 crores
- Revenue projection post-expansion: Close to Rs. 400 crores top line with EBITDA upwards of Rs. 100 crores.
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Personal Products
on management's own guidance
- Strong growth2
- Strong growth1
- EmamiGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Cupid latest results (Sep 2026)
Revenue
₹209 Cr
+132% YoY
Net profit
₹56 Cr
+133% YoY
Operating margin
36%
EPS
₹0.42
Cupid shareholding (Sep 2026)
Promoters
47.69%
+1.45 pp QoQ
FIIs
4.69%
+0.52 pp QoQ
DIIs
1.19%
+0.85 pp QoQ
Public
46.41%
−2.82 pp QoQ
Peers
Personal Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹2,024 Cr | 60.5 | |
| 2 | 40%+ | Flat | ₹458 Cr | 40.9 | |
| 3 | Emami | 20–40% | Flat | ₹17,821 Cr | 23.7 |
| 4 | 20–40% | Flat | ₹98 Cr | 8.9 | |
| 5 | 10–20% | Flat | ₹89,118 Cr | 42.0 | |
| 6 | 10–20% | Flat | ₹67,504 Cr | 33.1 |
Sign up free to see every company in the sector ranking and track Cupid.
Pro shows every company guiding 40%+ revenue growth →Full Personal Products rankingCupid announcements
All announcements →- Fundraise / allotmentMajor developmentCupid Q2 profit ₹5,622.45 lakh; board OKs Baazar Style warrant conversion
- Fundraise / allotmentNotableCupid Limited completes conversion of 30,00,000 Baazar Style Warrants into Equity Shares
- Acquisition / mergerNotableCupid Limited board approves South African manufacturing venture in principle
Financials of Cupid
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Cupid
Shareholding breakup across reporting periods.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters + | 45.06% | 44.80% | 44.80% | 45.62% | 42.51% | 42.51% | 42.51% | 45.56% | 45.56% | 46.03% | 46.24% | 47.69% |
| FIIs + | 0.45% | 5.19% | 5.97% | 3.33% | 3.14% | 1.63% | 0.95% | 2.58% | 1.48% | 1.01% | 4.17% | 4.69% |
| DIIs + | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.11% | 0.11% | 0.35% | 0.30% | 0.17% | 0.34% | 1.19% |
| Public + | 54.49% | 50.00% | 49.24% | 51.05% | 54.34% | 55.75% | 56.43% | 51.51% | 52.66% | 52.79% | 49.23% | 46.41% |
| No. of Shareholders | 25,582 | 33,761 | 95,639 | 1,12,236 | 1,16,374 | 1,23,379 | 99,813 | 97,483 | 1,45,806 | 2,09,610 | 2,95,432 | 4,70,414 |
Financials of Cupid
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 36 | 40 | 66 | 44 | 47 | 51 | 61 | 65 | 90 | 104 | 132 | 157 | 209 |
| YoY Sales growth | -21% | -7% | +59% | +25% | +30% | +27% | -7% | +47% | +91% | +106% | +116% | +142% | +132% |
| Expenses + | 29 | 28 | 32 | 32 | 31 | 35 | 43 | 43 | 56 | 59 | 82 | 95 | 133 |
| Operating Profit | 7 | 12 | 34 | 12 | 16 | 16 | 18 | 21 | 34 | 45 | 50 | 62 | 76 |
| OPM % | 20% | 30% | 51% | 26% | 34% | 31% | 30% | 33% | 38% | 43% | 38% | 40% | 36% |
| Other Income + | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 6 | 12 | 32 | 11 | 14 | 14 | 16 | 20 | 32 | 43 | 47 | 60 | 73 |
| Tax % | 20% | 24% | 26% | 22% | 29% | 21% | 28% | 23% | 25% | 24% | 24% | 26% | 23% |
| Net Profit + | 5 | 9 | 24 | 8 | 10 | 11 | 12 | 15 | 24 | 33 | 36 | 44 | 56 |
| EPS in Rs | 0.04 | 0.07 | 0.18 | 0.06 | 0.07 | 0.08 | 0.09 | 0.11 | 0.18 | 0.24 | 0.27 | 0.33 | 0.42 |
Financials of Cupid
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 44 | 61 | 84 | 81 | 85 | 160 | 143 | 133 | 159 | 172 | 183 | 358 | 602 |
| Sales growth | +128% | +38% | +37% | -4% | +6% | +87% | -11% | -7% | +20% | +8% | +7% | +95% | +126% |
| Expenses + | 32 | 36 | 50 | 53 | 65 | 108 | 107 | 109 | 118 | 121 | 141 | 239 | 369 |
| Operating Profit | 13 | 25 | 34 | 27 | 21 | 52 | 36 | 23 | 41 | 51 | 42 | 119 | 233 |
| OPM % | 29% | 41% | 41% | 34% | 24% | 33% | 25% | 17% | 26% | 30% | 23% | 33% | 39% |
| Other Income + | 1 | 2 | 1 | 1 | 2 | 3 | 5 | 4 | 5 | 7 | 19 | 32 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 3 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 5 | 5 |
| Profit before tax | 11 | 25 | 32 | 26 | 21 | 53 | 38 | 25 | 42 | 53 | 55 | 142 | 224 |
| Tax % | 33% | 36% | 37% | 34% | 27% | 24% | 24% | 30% | 25% | 24% | 25% | 24% | |
| Net Profit + | 8 | 16 | 21 | 17 | 15 | 40 | 29 | 17 | 32 | 40 | 41 | 108 | 170 |
| EPS in Rs | 0.06 | 0.12 | 0.15 | 0.13 | 0.11 | 0.30 | 0.22 | 0.13 | 0.24 | 0.30 | 0.30 | 0.81 | 1.26 |
| Dividend Payout % | 22% | 21% | 22% | 29% | 35% | 15% | 21% | 35% | 21% | 0% | 0% | 0% |
Financials of Cupid
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 27 | 134 | 134 |
| Reserves | 13 | 25 | 43 | 55 | 63 | 90 | 118 | 129 | 154 | 288 | 315 | 316 | 428 |
| Borrowings + | 2 | 1 | 0 | 2 | 2 | 31 | 0 | 9 | 6 | 12 | 19 | 56 | 114 |
| Other Liabilities + | 8 | 14 | 9 | 10 | 15 | 30 | 22 | 23 | 16 | 7 | 11 | 46 | 85 |
| Total Liabilities | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 | 553 | 762 |
| Fixed Assets + | 16 | 16 | 16 | 16 | 21 | 26 | 29 | 31 | 36 | 58 | 67 | 67 | 70 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 6 | 0 | 0 | 6 | 25 | 100 |
| Investments | 0 | 0 | 5 | 18 | 22 | 21 | 48 | 54 | 69 | 147 | 103 | 75 | 319 |
| Other Assets + | 19 | 35 | 42 | 44 | 50 | 114 | 74 | 84 | 83 | 114 | 196 | 386 | 273 |
| Total Assets | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 | 553 | 762 |
Financials of Cupid
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 7 | 13 | 20 | 3 | 18 | 19 | 42 | 10 | 33 | 8 | -11 | 46 |
| Cash from Investing Activity + | -1 | -1 | -5 | -9 | -14 | -37 | -9 | -13 | -22 | -80 | 45 | 28 |
| Cash from Financing Activity + | -3 | -6 | -4 | -3 | -5 | 16 | -33 | 3 | -11 | 99 | -1 | 35 |
| Net Cash Flow | 3 | 6 | 11 | -9 | -0 | -2 | 0 | -1 | -0 | 27 | 32 | 110 |
| Free Cash Flow | 6 | 11 | 17 | 1 | 12 | 8 | 38 | 2 | 30 | -17 | -31 | 21 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 69% | 76% | 94% | 50% | 119% | 60% | 142% | 83% | 106% | 41% | 5% | 66% |
Financials of Cupid
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 67 | 79 | 59 | 100 | 97 | 95 | 65 | 84 | 59 | 102 | 134 | 103 |
| Inventory Days | 155 | 60 | 133 | 259 | 168 | 437 | 230 | 197 | 229 | 184 | 450 | 350 |
| Days Payable | 84 | 27 | 80 | 162 | 135 | 579 | 168 | 134 | 105 | 1 | 13 | 153 |
| Cash Conversion Cycle | 139 | 112 | 112 | 198 | 130 | -46 | 127 | 147 | 183 | 285 | 570 | 301 |
| Working Capital Days | 58 | 77 | 67 | 130 | 108 | 40 | 87 | 87 | 77 | 123 | 210 | 119 |
| ROCE % | 48% | 79% | 72% | 43% | 29% | 50% | 28% | 17% | 26% | 22% | 17% | 34% |
Guidance history
How Cupid's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q3 FY24 call → | 40%+ | Up 2%+ | Planned | Planned | — |
| Q2 FY24 call → | 10–20% | Up 2%+ | Planned | None planned | Rising |
| Q1 FY24 call → | 10–20% | Flat | Planned | — | Flat |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
98 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,947 stocks |
|---|---|---|
| Last 12 months | +492.9% | 100% |
| Last 6 months | +220.0% | 100% |
| Last 3 months | +28.8% | 93% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,947 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Cupid: 0.4 × 100 + 0.4 × 100 + 0.2 × 93 = 98.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 17 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Cupid: frequently asked questions
What is Cupid share price today?
Cupid last traded at ₹365.85, with a market capitalisation of ₹49,194 Cr and a P/E ratio of 290.2.
What were Cupid's latest quarterly results?
For the quarter ended Sep 2026, Cupid reported revenue of ₹209 Cr (+132% year on year) and net profit of ₹56 Cr, with an operating margin of 36%.
Is Cupid's profit growing?
Net profit was ₹56 Cr in Sep 2026 against ₹24 Cr in Sep 2025, a change of +133%.
What is Cupid's EPS?
Cupid's earnings per share for the quarter ended Sep 2026 was ₹0.42.
What is the promoter holding in Cupid?
Promoters held 47.69% of Cupid in Sep 2026 (+1.45 pp versus Jun 2026).
How much do FIIs and DIIs hold in Cupid?
In Sep 2026, foreign institutional investors held 4.69% and domestic institutions (including mutual funds) held 1.19% of Cupid.
What is Cupid's ROE and ROCE?
Cupid's return on equity is 27.6% and its return on capital employed is 33.9%.
Does Cupid pay a dividend?
Cupid's dividend yield is 0% at the current price; see the Cupid dividends page for past payouts.
Which sector does Cupid belong to?
Cupid is in the Personal Products sector. Its peer comparison and sector ranking are on this page.
What did Cupid's management say on the latest earnings call?
Arthneeti's analysis of the Q2 FY27 earnings call covers revenue, margins, capex and fundraising guidance from Cupid's management.
How does Arthneeti AI analyse Cupid?
Arthneeti reads Cupid's earnings call transcripts and filings and scores revenue growth, margins, capex and fundraising, then ranks the company against its sector.
Continue your research
What Cupid's management said in earlier quarters
Others in Personal Products this season
- Anondita Medicare (Q2 FY27)
Revenue (Standalone)** for H1 FY27: ₹5,786.31 Lakhs, up 21.43% YoY from ₹4,765.06 Lakhs in H1 FY26 . Key investor presentation takeaways from Anondita Medicare
- Gillette India (Q2 FY27)
Revenue from operations for the quarter ended 30th September 2026: ₹84,610 lakh (Page 3) . Key results statement takeaways from Gillette India Ltd's Q2 FY27 ear
- Honasa Consumer (Q2 FY27)
Younger brands, excluding The Derma Co., are growing healthily at 40%+ year-on-year, with the overall portfolio showing strong momentum across online and…
- Emami (Q2 FY27)
Volume growth for domestic business recorded 43% in Q2 and 26% on a like-to-like basis, indicating strong demand. Key concall takeaways from Emami Ltd's Q2…
